Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in TaxesChange in TaxesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evaxion A (EVAX) Change in Cash (2020 - 2022)

Evaxion A posted quarterly Change in Cash of -$5.6 million for Q2 2022, down 143.25% year-on-year from $12.9 million in Q2 2021, and down 817.13% on a QoQ basis from -$607000.0 in Q1 2022.

Evaxion A (EVAX) has 3 years of Change in Cash data on file, last reported at -$5.6 million in Q2 2022.

  • For the quarter ending Q2 2022, Change in Cash fell 143.25% year-over-year to -$5.6 million; the trailing twelve-month figure through Jun 2022 stood at $12.9 million (down 51.66% YoY), and the FY2025 full-year result was $15.8 million, up 8379.03% from the prior year.
  • Change in Cash for Q2 2022 stood at -$5.6 million, down from -$607000.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $20.9 million in Q1 2021 and bottomed at -$5.6 million in Q2 2022.
  • The 3-year median for Change in Cash is -$1.2 million (2020), against an average of $2.9 million.
  • The widest annual swing landed in 2021, when Change in Cash jumped 785.14%; it then plunged 143.25% in 2022.
  • A 3-year view of Change in Cash shows it stood at -$1.7 million in 2020, then surged by 462.31% to $6.2 million in 2021, then sank by 190.07% to -$5.6 million in 2022.
  • The last three Change in Cash figures came in at -$5.6 million (Q2 2022), -$607000.0 (Q1 2022), and $6.2 million (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.44 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 623.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 417.10 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -153.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.61 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn - 57.19 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 -5.57 Mn
Mar 31, 2022 -607,000.00
Sep 30, 2021 6.18 Mn
Jun 30, 2021 12.87 Mn
Mar 31, 2021 20.89 Mn
Sep 30, 2020 -1.71 Mn
Jun 30, 2020 -5.42 Mn
Mar 31, 2020 -3.05 Mn